AQIM-I

N/A

Report date: 2023/12/12 10:19:22
NME

Base Information

Drug NameAQIM-I
Drug Alias NameAQIM-I
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin enhancer-binding factor 3 modulators
TargetsInterleukin enhancer-binding factor 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiaotong University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A